北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学临床肿瘤学院  > 医学影像科  > 期刊论文
学科主题: 临床医学
题名:
Effect of Recombinant Adenovirus-p53 Combined With Radiotherapy on Long-Term Prognosis of Advanced Nasopharyngeal Carcinoma
作者: Pan, Jian-ji1; Zhang, Shan-wen1; Chen, Chuan-beng1; Xiao, Shao-wen1; Sun, Yan1; Liu, Chang-qin1; Su, Xing1; Li, Dong-ming1; Xu, Gang1; Xu, Bo1; Lu, You-yong1
刊名: JOURNAL OF CLINICAL ONCOLOGY
发表日期: 2009-02-10
DOI: 10.1200/JCO.2008.18.9670
卷: 27, 期:5, 页:799-804
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Oncology
研究领域[WOS]: Oncology
关键词[WOS]: WILD-TYPE P53 ; SQUAMOUS-CELL CARCINOMA ; GENE-TRANSFER ; LUNG-CANCER ; IN-VIVO ; THERAPY ; EXPRESSION ; HEAD ; ANGIOGENESIS ; MUTATIONS
英文摘要:

Purpose

To centrally assess the safety, efficacy, and 6-year follow-up of recombinant adenovirus-p53 (rAd-p53) combined with radiotherapy (RT) for patients with nasopharyngeal carcinoma (NPC).

Patients and Methods

A randomized controlled clinical study on rAd-p53 combined with RT in 42 patients with NPC was compared with a control group of 40 patients with NPC treated with RT alone. In the group receiving rAd-p53 combined with RT, rAd-p53 was intratumorally injected once a week for 8 weeks. Concurrent RT (70 Gy in 35 fractions) was given to the nasopharyngeal tumor and neck lymph node. Patients and tumors were monitored for adverse events and responses.

Results

rAd-p53-specific p53 mRNA was detected in postinjection of rAd-p53 biopsies from 16 (94.1%) of 17 patients. Upregulation of p21/WAF1 and Bax and downregulation of vascular endothelial growth factor were observed in postinjection tumor biopsy. Complete response rate in the group receiving rAd-p53 combined with RT was observed at 2.73 times that of the group receiving RT alone (66.7% v 24.4%). Six-year follow-up data showed that rAd-p53 significantly increased the 5-year locoregional tumor control rate by 25.3% for patients with NPC treated with irradiation (P = .002). The 5-year overall survival rate and 5-year disease-free survival rate of the group receiving rAd-p53 combined with RT were 7.5% (P = .34) and 11.7% (P = .21) higher than those of the group receiving RT alone. No dose-limiting toxicity or adverse events appeared, except for transient fever after rAd-p53 administration.

Conclusion

In patients with NPC, rAd-p53 was safe and biologically active. Our results indicated that rAd-p53 improves radiotherapeutic tumor control and survival rate in patients with NPC.

语种: 英语
项目资助者: National Science Committee
WOS记录号: WOS:000263139800022
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/50640
Appears in Collections:北京大学临床肿瘤学院_医学影像科_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst, Dept Radiotherapy, Beijing 100036, Peoples R China
2.Fujian Prov Canc Hosp, Fuzhou, Peoples R China

Recommended Citation:
Pan, Jian-ji,Zhang, Shan-wen,Chen, Chuan-beng,et al. Effect of Recombinant Adenovirus-p53 Combined With Radiotherapy on Long-Term Prognosis of Advanced Nasopharyngeal Carcinoma[J]. JOURNAL OF CLINICAL ONCOLOGY,2009,27(5):799-804.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Pan, Jian-ji]'s Articles
[Zhang, Shan-wen]'s Articles
[Chen, Chuan-beng]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Pan, Jian-ji]‘s Articles
[Zhang, Shan-wen]‘s Articles
[Chen, Chuan-beng]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace